nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromocriptine—type 2 diabetes mellitus—type 1 diabetes mellitus	0.691	1	CtDrD
Bromocriptine—ADRB1—type 1 diabetes mellitus	0.214	1	CbGaD
Bromocriptine—HTR7—umbilical artery—type 1 diabetes mellitus	0.00571	0.25	CbGeAlD
Bromocriptine—HTR2A—arteriole—type 1 diabetes mellitus	0.00205	0.0896	CbGeAlD
Bromocriptine—HTR7—autonomic nervous system—type 1 diabetes mellitus	0.00141	0.0616	CbGeAlD
Bromocriptine—DRD1—nerve—type 1 diabetes mellitus	0.00127	0.0554	CbGeAlD
Bromocriptine—HTR7—peripheral nervous system—type 1 diabetes mellitus	0.00101	0.0444	CbGeAlD
Bromocriptine—HTR2A—autonomic nervous system—type 1 diabetes mellitus	0.000876	0.0384	CbGeAlD
Bromocriptine—HTR7—nerve—type 1 diabetes mellitus	0.00079	0.0346	CbGeAlD
Bromocriptine—DRD2—nerve—type 1 diabetes mellitus	0.000747	0.0327	CbGeAlD
Bromocriptine—ADRA2A—peripheral nervous system—type 1 diabetes mellitus	0.000744	0.0326	CbGeAlD
Bromocriptine—Burning sensation—Ramipril—type 1 diabetes mellitus	0.000686	0.0493	CcSEcCtD
Bromocriptine—HTR2A—peripheral nervous system—type 1 diabetes mellitus	0.000632	0.0277	CbGeAlD
Bromocriptine—HTR2A—nerve—type 1 diabetes mellitus	0.000493	0.0216	CbGeAlD
Bromocriptine—Vasculitis—Ramipril—type 1 diabetes mellitus	0.000488	0.0351	CcSEcCtD
Bromocriptine—DRD5—lymphoid tissue—type 1 diabetes mellitus	0.000487	0.0213	CbGeAlD
Bromocriptine—ADRA1B—kidney—type 1 diabetes mellitus	0.000465	0.0204	CbGeAlD
Bromocriptine—Lightheadedness—Ramipril—type 1 diabetes mellitus	0.000426	0.0306	CcSEcCtD
Bromocriptine—Nasal congestion—Ramipril—type 1 diabetes mellitus	0.00038	0.0273	CcSEcCtD
Bromocriptine—HTR1B—cardiovascular system—type 1 diabetes mellitus	0.000359	0.0157	CbGeAlD
Bromocriptine—Hypoglycaemia—Ramipril—type 1 diabetes mellitus	0.000354	0.0255	CcSEcCtD
Bromocriptine—Cerebrovascular accident—Ramipril—type 1 diabetes mellitus	0.000353	0.0254	CcSEcCtD
Bromocriptine—HTR1D—cardiovascular system—type 1 diabetes mellitus	0.000348	0.0152	CbGeAlD
Bromocriptine—Disturbance in sexual arousal—Ramipril—type 1 diabetes mellitus	0.000343	0.0247	CcSEcCtD
Bromocriptine—HTR1D—kidney—type 1 diabetes mellitus	0.00034	0.0149	CbGeAlD
Bromocriptine—ADRB1—cardiovascular system—type 1 diabetes mellitus	0.000338	0.0148	CbGeAlD
Bromocriptine—HTR2B—cardiovascular system—type 1 diabetes mellitus	0.000323	0.0142	CbGeAlD
Bromocriptine—Orthostatic hypotension—Ramipril—type 1 diabetes mellitus	0.000316	0.0227	CcSEcCtD
Bromocriptine—Abdominal pain upper—Ramipril—type 1 diabetes mellitus	0.000316	0.0227	CcSEcCtD
Bromocriptine—Cramp muscle—Ramipril—type 1 diabetes mellitus	0.000311	0.0224	CcSEcCtD
Bromocriptine—DRD2—retina—type 1 diabetes mellitus	0.00031	0.0136	CbGeAlD
Bromocriptine—Dysphagia—Ramipril—type 1 diabetes mellitus	0.000299	0.0215	CcSEcCtD
Bromocriptine—Influenza—Ramipril—type 1 diabetes mellitus	0.000299	0.0215	CcSEcCtD
Bromocriptine—HTR1A—cardiovascular system—type 1 diabetes mellitus	0.00029	0.0127	CbGeAlD
Bromocriptine—Abdominal discomfort—Ramipril—type 1 diabetes mellitus	0.000287	0.0206	CcSEcCtD
Bromocriptine—ADRA2C—nephron tubule—type 1 diabetes mellitus	0.000283	0.0124	CbGeAlD
Bromocriptine—ADRA2A—islet of Langerhans—type 1 diabetes mellitus	0.000281	0.0123	CbGeAlD
Bromocriptine—HTR7—cardiovascular system—type 1 diabetes mellitus	0.000277	0.0121	CbGeAlD
Bromocriptine—HTR7—kidney—type 1 diabetes mellitus	0.000271	0.0119	CbGeAlD
Bromocriptine—ADRA1A—cardiovascular system—type 1 diabetes mellitus	0.000267	0.0117	CbGeAlD
Bromocriptine—Acute coronary syndrome—Ramipril—type 1 diabetes mellitus	0.000263	0.0189	CcSEcCtD
Bromocriptine—Myocardial infarction—Ramipril—type 1 diabetes mellitus	0.000261	0.0188	CcSEcCtD
Bromocriptine—Sinusitis—Ramipril—type 1 diabetes mellitus	0.00025	0.018	CcSEcCtD
Bromocriptine—ADRA2C—kidney—type 1 diabetes mellitus	0.000249	0.0109	CbGeAlD
Bromocriptine—ADRA2C—pancreas—type 1 diabetes mellitus	0.000247	0.0108	CbGeAlD
Bromocriptine—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.000236	0.0169	CcSEcCtD
Bromocriptine—Connective tissue disorder—Ramipril—type 1 diabetes mellitus	0.000235	0.0169	CcSEcCtD
Bromocriptine—Visual impairment—Ramipril—type 1 diabetes mellitus	0.000231	0.0166	CcSEcCtD
Bromocriptine—ADRA1A—lymphoid tissue—type 1 diabetes mellitus	0.000224	0.00983	CbGeAlD
Bromocriptine—Tinnitus—Ramipril—type 1 diabetes mellitus	0.000223	0.016	CcSEcCtD
Bromocriptine—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.000216	0.0155	CcSEcCtD
Bromocriptine—Arrhythmia—Ramipril—type 1 diabetes mellitus	0.000214	0.0154	CcSEcCtD
Bromocriptine—Alopecia—Ramipril—type 1 diabetes mellitus	0.000211	0.0152	CcSEcCtD
Bromocriptine—Mental disorder—Ramipril—type 1 diabetes mellitus	0.00021	0.0151	CcSEcCtD
Bromocriptine—Tension—Ramipril—type 1 diabetes mellitus	0.000204	0.0147	CcSEcCtD
Bromocriptine—HTR2A—retina—type 1 diabetes mellitus	0.000204	0.00894	CbGeAlD
Bromocriptine—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.000204	0.0147	CcSEcCtD
Bromocriptine—Nervousness—Ramipril—type 1 diabetes mellitus	0.000202	0.0145	CcSEcCtD
Bromocriptine—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.0002	0.0144	CcSEcCtD
Bromocriptine—ADRA2A—pancreas—type 1 diabetes mellitus	0.000197	0.00865	CbGeAlD
Bromocriptine—Agitation—Ramipril—type 1 diabetes mellitus	0.000191	0.0138	CcSEcCtD
Bromocriptine—Vertigo—Ramipril—type 1 diabetes mellitus	0.000187	0.0135	CcSEcCtD
Bromocriptine—Syncope—Ramipril—type 1 diabetes mellitus	0.000187	0.0134	CcSEcCtD
Bromocriptine—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.000183	0.0132	CcSEcCtD
Bromocriptine—Convulsion—Ramipril—type 1 diabetes mellitus	0.00018	0.013	CcSEcCtD
Bromocriptine—Anxiety—Ramipril—type 1 diabetes mellitus	0.000177	0.0127	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.000176	0.0127	CcSEcCtD
Bromocriptine—Dry mouth—Ramipril—type 1 diabetes mellitus	0.000173	0.0125	CcSEcCtD
Bromocriptine—HTR2A—cardiovascular system—type 1 diabetes mellitus	0.000173	0.00756	CbGeAlD
Bromocriptine—Confusional state—Ramipril—type 1 diabetes mellitus	0.000171	0.0123	CcSEcCtD
Bromocriptine—Oedema—Ramipril—type 1 diabetes mellitus	0.00017	0.0122	CcSEcCtD
Bromocriptine—HTR2A—kidney—type 1 diabetes mellitus	0.000169	0.0074	CbGeAlD
Bromocriptine—Shock—Ramipril—type 1 diabetes mellitus	0.000167	0.012	CcSEcCtD
Bromocriptine—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.000167	0.012	CcSEcCtD
Bromocriptine—Tachycardia—Ramipril—type 1 diabetes mellitus	0.000166	0.0119	CcSEcCtD
Bromocriptine—Skin disorder—Ramipril—type 1 diabetes mellitus	0.000165	0.0119	CcSEcCtD
Bromocriptine—Anorexia—Ramipril—type 1 diabetes mellitus	0.000162	0.0116	CcSEcCtD
Bromocriptine—Hypotension—Ramipril—type 1 diabetes mellitus	0.000159	0.0114	CcSEcCtD
Bromocriptine—ABCB1—islet of Langerhans—type 1 diabetes mellitus	0.000156	0.00685	CbGeAlD
Bromocriptine—CYP3A4—kidney—type 1 diabetes mellitus	0.000156	0.00685	CbGeAlD
Bromocriptine—Insomnia—Ramipril—type 1 diabetes mellitus	0.000154	0.0111	CcSEcCtD
Bromocriptine—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.000153	0.011	CcSEcCtD
Bromocriptine—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.000152	0.0109	CcSEcCtD
Bromocriptine—Somnolence—Ramipril—type 1 diabetes mellitus	0.000151	0.0109	CcSEcCtD
Bromocriptine—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.00015	0.0108	CcSEcCtD
Bromocriptine—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.000148	0.0106	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.000147	0.0106	CcSEcCtD
Bromocriptine—Fatigue—Ramipril—type 1 diabetes mellitus	0.000147	0.0105	CcSEcCtD
Bromocriptine—Constipation—Ramipril—type 1 diabetes mellitus	0.000145	0.0105	CcSEcCtD
Bromocriptine—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.00014	0.0101	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.000139	0.00999	CcSEcCtD
Bromocriptine—Urticaria—Ramipril—type 1 diabetes mellitus	0.000135	0.00971	CcSEcCtD
Bromocriptine—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.000134	0.00966	CcSEcCtD
Bromocriptine—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.000134	0.00966	CcSEcCtD
Bromocriptine—ABCB1—retina—type 1 diabetes mellitus	0.000134	0.00586	CbGeAlD
Bromocriptine—ABCB1—nephron tubule—type 1 diabetes mellitus	0.000126	0.00552	CbGeAlD
Bromocriptine—Asthenia—Ramipril—type 1 diabetes mellitus	0.000122	0.00877	CcSEcCtD
Bromocriptine—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.000116	0.00836	CcSEcCtD
Bromocriptine—ABCB1—cardiovascular system—type 1 diabetes mellitus	0.000113	0.00496	CbGeAlD
Bromocriptine—Dizziness—Ramipril—type 1 diabetes mellitus	0.000112	0.00808	CcSEcCtD
Bromocriptine—ABCB1—kidney—type 1 diabetes mellitus	0.000111	0.00485	CbGeAlD
Bromocriptine—ABCB1—pancreas—type 1 diabetes mellitus	0.00011	0.00482	CbGeAlD
Bromocriptine—Vomiting—Ramipril—type 1 diabetes mellitus	0.000108	0.00777	CcSEcCtD
Bromocriptine—Rash—Ramipril—type 1 diabetes mellitus	0.000107	0.00771	CcSEcCtD
Bromocriptine—Dermatitis—Ramipril—type 1 diabetes mellitus	0.000107	0.0077	CcSEcCtD
Bromocriptine—Headache—Ramipril—type 1 diabetes mellitus	0.000107	0.00766	CcSEcCtD
Bromocriptine—Nausea—Ramipril—type 1 diabetes mellitus	0.000101	0.00726	CcSEcCtD
Bromocriptine—ABCB1—lymphoid tissue—type 1 diabetes mellitus	9.51e-05	0.00417	CbGeAlD
Bromocriptine—HTR7—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.77e-06	6.41e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—APOC3—type 1 diabetes mellitus	3.76e-06	6.39e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.75e-06	6.37e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.74e-06	6.35e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	3.74e-06	6.35e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—E2F1—type 1 diabetes mellitus	3.71e-06	6.3e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—INS—type 1 diabetes mellitus	3.71e-06	6.3e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—GSTT1—type 1 diabetes mellitus	3.69e-06	6.27e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—INS—type 1 diabetes mellitus	3.69e-06	6.27e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—GCG—type 1 diabetes mellitus	3.69e-06	6.26e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.68e-06	6.25e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	3.68e-06	6.25e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.67e-06	6.23e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—ERBB3—type 1 diabetes mellitus	3.66e-06	6.22e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—INS—type 1 diabetes mellitus	3.66e-06	6.21e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—INS—type 1 diabetes mellitus	3.66e-06	6.21e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CD86—type 1 diabetes mellitus	3.63e-06	6.17e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.61e-06	6.13e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	3.6e-06	6.12e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CCR5—type 1 diabetes mellitus	3.6e-06	6.12e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.58e-06	6.09e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	3.57e-06	6.06e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—IL2RA—type 1 diabetes mellitus	3.55e-06	6.03e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CCR5—type 1 diabetes mellitus	3.54e-06	6.02e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.54e-06	6.01e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.54e-06	6.01e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	3.53e-06	5.99e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—CD80—type 1 diabetes mellitus	3.53e-06	5.99e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—IL2—type 1 diabetes mellitus	3.52e-06	5.98e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling by GPCR—EGFR—type 1 diabetes mellitus	3.52e-06	5.98e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling by GPCR—EGFR—type 1 diabetes mellitus	3.52e-06	5.98e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.51e-06	5.96e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—CD80—type 1 diabetes mellitus	3.49e-06	5.94e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	3.49e-06	5.93e-05	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.49e-06	5.93e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	3.47e-06	5.9e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CCR5—type 1 diabetes mellitus	3.47e-06	5.89e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—IL2—type 1 diabetes mellitus	3.46e-06	5.89e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—E2F1—type 1 diabetes mellitus	3.45e-06	5.86e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.45e-06	5.85e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	3.42e-06	5.81e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	3.4e-06	5.78e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—IL2—type 1 diabetes mellitus	3.39e-06	5.76e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—ALB—type 1 diabetes mellitus	3.38e-06	5.74e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—CD80—type 1 diabetes mellitus	3.37e-06	5.73e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—CD80—type 1 diabetes mellitus	3.36e-06	5.7e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—INS—type 1 diabetes mellitus	3.33e-06	5.66e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.31e-06	5.63e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—INS—type 1 diabetes mellitus	3.3e-06	5.61e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	3.28e-06	5.57e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.27e-06	5.55e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.27e-06	5.55e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—CD80—type 1 diabetes mellitus	3.26e-06	5.54e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.25e-06	5.52e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—NOS3—type 1 diabetes mellitus	3.23e-06	5.49e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CCR5—type 1 diabetes mellitus	3.22e-06	5.48e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.22e-06	5.47e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—CD80—type 1 diabetes mellitus	3.21e-06	5.46e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	3.21e-06	5.45e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.21e-06	5.45e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.21e-06	5.45e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.21e-06	5.45e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.2e-06	5.44e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—IL2—type 1 diabetes mellitus	3.2e-06	5.44e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—IL2—type 1 diabetes mellitus	3.2e-06	5.43e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.19e-06	5.42e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—INS—type 1 diabetes mellitus	3.19e-06	5.41e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.18e-06	5.41e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.18e-06	5.4e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.18e-06	5.4e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—EGFR—type 1 diabetes mellitus	3.18e-06	5.4e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—IL2—type 1 diabetes mellitus	3.18e-06	5.4e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	3.18e-06	5.4e-05	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.17e-06	5.39e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—INS—type 1 diabetes mellitus	3.17e-06	5.39e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.16e-06	5.37e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—IL2—type 1 diabetes mellitus	3.15e-06	5.36e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—CAT—type 1 diabetes mellitus	3.12e-06	5.3e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.11e-06	5.29e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—IL2—type 1 diabetes mellitus	3.11e-06	5.28e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	3.1e-06	5.27e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.09e-06	5.26e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—INS—type 1 diabetes mellitus	3.08e-06	5.24e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.08e-06	5.24e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	3.07e-06	5.21e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.07e-06	5.21e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.06e-06	5.21e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—IL2—type 1 diabetes mellitus	3.06e-06	5.2e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—EGFR—type 1 diabetes mellitus	3.05e-06	5.18e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.05e-06	5.17e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—INS—type 1 diabetes mellitus	3.03e-06	5.16e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—INS—type 1 diabetes mellitus	3e-06	5.09e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—IGF1—type 1 diabetes mellitus	2.98e-06	5.07e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—TYK2—type 1 diabetes mellitus	2.98e-06	5.06e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—EGFR—type 1 diabetes mellitus	2.97e-06	5.04e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CD80—type 1 diabetes mellitus	2.96e-06	5.03e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—TYK2—type 1 diabetes mellitus	2.95e-06	5.01e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—GCG—type 1 diabetes mellitus	2.94e-06	5e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—IGF1—type 1 diabetes mellitus	2.94e-06	4.99e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.93e-06	4.97e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—NOS3—type 1 diabetes mellitus	2.92e-06	4.96e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—IL2—type 1 diabetes mellitus	2.92e-06	4.96e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—EGFR—type 1 diabetes mellitus	2.92e-06	4.96e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	2.92e-06	4.96e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CD80—type 1 diabetes mellitus	2.91e-06	4.95e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.91e-06	4.94e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	2.9e-06	4.93e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—NOS3—type 1 diabetes mellitus	2.9e-06	4.92e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CD80—type 1 diabetes mellitus	2.85e-06	4.85e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	2.85e-06	4.84e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	2.85e-06	4.84e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—TYK2—type 1 diabetes mellitus	2.83e-06	4.81e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—INS—type 1 diabetes mellitus	2.8e-06	4.75e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	2.79e-06	4.75e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—NOS3—type 1 diabetes mellitus	2.78e-06	4.72e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.76e-06	4.69e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—TYK2—type 1 diabetes mellitus	2.76e-06	4.68e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—IL2—type 1 diabetes mellitus	2.76e-06	4.68e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—INS—type 1 diabetes mellitus	2.75e-06	4.68e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—ALB—type 1 diabetes mellitus	2.75e-06	4.67e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.74e-06	4.66e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.72e-06	4.63e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.72e-06	4.63e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—IL2—type 1 diabetes mellitus	2.72e-06	4.62e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—IL2—type 1 diabetes mellitus	2.72e-06	4.62e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—TYK2—type 1 diabetes mellitus	2.71e-06	4.61e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—IGF1—type 1 diabetes mellitus	2.71e-06	4.6e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.7e-06	4.6e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.7e-06	4.6e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—NOS3—type 1 diabetes mellitus	2.7e-06	4.59e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—INS—type 1 diabetes mellitus	2.7e-06	4.58e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.69e-06	4.58e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	2.69e-06	4.58e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.69e-06	4.57e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.67e-06	4.54e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—IGF1—type 1 diabetes mellitus	2.66e-06	4.52e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—NOS3—type 1 diabetes mellitus	2.66e-06	4.52e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CD80—type 1 diabetes mellitus	2.65e-06	4.5e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	2.65e-06	4.5e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—NOS3—type 1 diabetes mellitus	2.63e-06	4.46e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.62e-06	4.45e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	2.61e-06	4.43e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	2.59e-06	4.41e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.58e-06	4.38e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—INS—type 1 diabetes mellitus	2.5e-06	4.26e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—TYK2—type 1 diabetes mellitus	2.5e-06	4.25e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—CAT—type 1 diabetes mellitus	2.49e-06	4.23e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.48e-06	4.21e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—IL2—type 1 diabetes mellitus	2.48e-06	4.21e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.46e-06	4.19e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—TYK2—type 1 diabetes mellitus	2.46e-06	4.18e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.46e-06	4.18e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.46e-06	4.18e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—IL2—type 1 diabetes mellitus	2.45e-06	4.17e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—NOS3—type 1 diabetes mellitus	2.45e-06	4.17e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.45e-06	4.16e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.45e-06	4.15e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.44e-06	4.15e-05	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—IL6—type 1 diabetes mellitus	2.44e-06	4.14e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.43e-06	4.13e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—IGF1—type 1 diabetes mellitus	2.42e-06	4.12e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—NOS3—type 1 diabetes mellitus	2.41e-06	4.1e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	2.41e-06	4.1e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	2.41e-06	4.09e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.38e-06	4.04e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.37e-06	4.03e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—IL2—type 1 diabetes mellitus	2.37e-06	4.02e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	2.36e-06	4.02e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.36e-06	4.01e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.36e-06	4e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—IL2—type 1 diabetes mellitus	2.36e-06	4e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.35e-06	3.98e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.34e-06	3.98e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.32e-06	3.94e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.3e-06	3.9e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—IL2—type 1 diabetes mellitus	2.29e-06	3.89e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.29e-06	3.89e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.29e-06	3.89e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.28e-06	3.88e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	2.27e-06	3.86e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.26e-06	3.84e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—IL2—type 1 diabetes mellitus	2.26e-06	3.83e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.24e-06	3.81e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—TYK2—type 1 diabetes mellitus	2.24e-06	3.8e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.23e-06	3.8e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—NOS3—type 1 diabetes mellitus	2.2e-06	3.73e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.11e-06	3.58e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.08e-06	3.54e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.08e-06	3.54e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—IL2—type 1 diabetes mellitus	2.08e-06	3.53e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.08e-06	3.53e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.08e-06	3.53e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—INS—type 1 diabetes mellitus	2.07e-06	3.52e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.07e-06	3.52e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.07e-06	3.51e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.05e-06	3.48e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—IL2—type 1 diabetes mellitus	2.05e-06	3.48e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.04e-06	3.46e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.01e-06	3.41e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—IL2—type 1 diabetes mellitus	2e-06	3.4e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—IL6—type 1 diabetes mellitus	1.99e-06	3.39e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.99e-06	3.39e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.98e-06	3.37e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.93e-06	3.28e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	1.92e-06	3.27e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—ALB—type 1 diabetes mellitus	1.9e-06	3.23e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.9e-06	3.23e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.89e-06	3.22e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—IL6—type 1 diabetes mellitus	1.88e-06	3.2e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—IL6—type 1 diabetes mellitus	1.88e-06	3.19e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.88e-06	3.19e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—IL6—type 1 diabetes mellitus	1.87e-06	3.17e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.86e-06	3.17e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—IL2—type 1 diabetes mellitus	1.86e-06	3.16e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—IL6—type 1 diabetes mellitus	1.85e-06	3.15e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—IL6—type 1 diabetes mellitus	1.83e-06	3.11e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—NOS3—type 1 diabetes mellitus	1.82e-06	3.09e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.81e-06	3.08e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.8e-06	3.06e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—IL6—type 1 diabetes mellitus	1.8e-06	3.06e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.75e-06	2.98e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.75e-06	2.97e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.73e-06	2.93e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.72e-06	2.93e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—IL6—type 1 diabetes mellitus	1.72e-06	2.92e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.69e-06	2.87e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—INS—type 1 diabetes mellitus	1.65e-06	2.81e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—IL6—type 1 diabetes mellitus	1.62e-06	2.75e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—IL6—type 1 diabetes mellitus	1.6e-06	2.71e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—IL6—type 1 diabetes mellitus	1.6e-06	2.71e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.59e-06	2.7e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.57e-06	2.66e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.57e-06	2.66e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.53e-06	2.6e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—ALB—type 1 diabetes mellitus	1.52e-06	2.58e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—IL6—type 1 diabetes mellitus	1.46e-06	2.47e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—NOS3—type 1 diabetes mellitus	1.45e-06	2.46e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—IL6—type 1 diabetes mellitus	1.44e-06	2.45e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.42e-06	2.42e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—IL6—type 1 diabetes mellitus	1.39e-06	2.37e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—IL6—type 1 diabetes mellitus	1.39e-06	2.35e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—IL6—type 1 diabetes mellitus	1.35e-06	2.29e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—IL6—type 1 diabetes mellitus	1.33e-06	2.25e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	1.28e-06	2.17e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—IL6—type 1 diabetes mellitus	1.22e-06	2.08e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—IL6—type 1 diabetes mellitus	1.2e-06	2.04e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—IL6—type 1 diabetes mellitus	1.18e-06	2e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	1.17e-06	1.99e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	1.12e-06	1.9e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—IL6—type 1 diabetes mellitus	1.09e-06	1.86e-05	CbGpPWpGaD
